Home / BusinessBusinessFinancial TimesBusinessFinancial Times·Aug 3, 2026·1 min readStruggling to make sense of AstraZeneca-BMSAll about oncology? A cardio workout? Patent-cliff avoidance? American dreaming?View original source — Financial Times ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessThe New York TimesBusinessAug 3, 2026 · 1 minSpaceX’s Stock Lockup Is Expiring. Prepare for a Bumpy Ride.The New York TimesBusinessTASSBusinessAug 3, 2026 · 1 minRussian oil supplies to India in July reach highest level since 2022TASSBusinessPortugal ResidentBusinessAug 3, 2026 · 1 minPortuguese economy defies turmoil as 2% growth comes within reachPortugal ResidentBusinessMarketWatchBusinessAug 3, 2026 · 1 minAmerican manufacturers grow at fastest clip in 4 years due to AI boom, but all is not wellMarketWatch
BusinessThe New York TimesBusinessAug 3, 2026 · 1 minSpaceX’s Stock Lockup Is Expiring. Prepare for a Bumpy Ride.The New York Times
BusinessTASSBusinessAug 3, 2026 · 1 minRussian oil supplies to India in July reach highest level since 2022TASS
BusinessPortugal ResidentBusinessAug 3, 2026 · 1 minPortuguese economy defies turmoil as 2% growth comes within reachPortugal Resident
BusinessMarketWatchBusinessAug 3, 2026 · 1 minAmerican manufacturers grow at fastest clip in 4 years due to AI boom, but all is not wellMarketWatch